Home         Register       Sign In


Company Profile

Company Info

Regeneron
Tarrytown, , United States


 

Company Description:

Regeneron is expanding its genomics efforts and operations, building upon its strengths in mouse genetics (VelociGene®; VelocImmune® and related technologies) and genetics-driven drug discovery and development (e.g. Interleukin-1 blocker rilonacept, FDA approved in 2008; PCSK9 antibody alirocumab, in Phase 3; and several other important pipeline medicines). Specific activities being scaled up will include whole exome and whole genome sequencing projects, functional biology and mouse genetics for disease modeling, and translational research integrating genetics discovery research with Regeneron's growing pipeline development efforts. Along with others in industry and academia, Regeneron has long seen human genetics and genomics as essential platforms for facilitating and enabling drug discovery and development; we believe technological advances and other trends now make it possible to more fully realize this potential.

 Goals for Regeneron's programs include target discovery, indication discovery, and patient-disease stratification through the use of human genetics and related genomic sciences. Regeneron’s interests encompass a breadth of different areas spanning Mendelian and family frameworks, large scale population genetics (both common and rare variants), and gene-gene interactions. The company will rely on its internal assets and technologies as well as continue to collaborate with investigators around the world in pursuing exciting genetics discovery projects.

Jobs by Regeneron
Results: 0 Jobs
Number of jobs per page:

There are no postings meeting the criteria you specified

Title Company Location Posted

Home     My Account     Find Jobs     Post Resumes     Search Resumes     Post Jobs     Contact   About Us   Sitemap
Powered by: